Eryaspase: Completed Phase II enrollment

Erytech completed enrollment of 139 patients in an open-label, French Phase II trial comparing ERY-ASP with gemcitabine or FOLFOX chemotherapy vs. gemcitabine or FOLFOX alone. ...